Pfizer Asks FDA for Emergency Approval of Its COVID Antiviral Pill
TUESDAY, Nov. 16, 2021 (HealthDay News) — Pfizer announced Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its new antiviral pill in people at high risk for severe COVID-19. “With more than 5 million deaths and countless lives impacted by thisContinue Reading










